Sanyal Debmalya, Chatterjee Sudip
Department of Endocrinology, KPC Medical College, Kolkata, West Bengal, India.
Consultant Endocrinologist, Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, West Bengal, India.
Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):274-276. doi: 10.4103/ijem.IJEM_590_17.
It is generally accepted that renal and eye changes in diabetes are concordant. There are however a fair number of patients with diabetes who have end-stage renal disease (ESRD) without any of the typical eye changes. The present study highlights the discordance between retinopathy and nephropathy and describes a series of patients of long-standing diabetes undergoing renal transplant who had little or no evidence of retinopathy.
All patients with ESRD undergoing renal transplants underwent comprehensive fundus evaluation including dilated indirect ophthalmoscopy, slit lamp biomicroscopy, and fundus photography. The patients' age, gender, physical parameters (body mass index and blood pressure), duration of diabetes, glycosylated hemoglobin (HbA1c), albumin creatinine ratio, and presence of diabetic peripheral neuropathy (DPN) were determined. Renal histopathology was reviewed, if available.
Five patients with diabetic nephropathy (DN) underwent renal transplant and had no evidence of diabetic retinopathy (DR) or up to two microaneurysms per fundus. All the patients were between 50 and 65 (mean ± standard deviation - 58.6 ± 4.67) years of age. The mean duration of diabetes was 16 ± 2.91 years. All had poor glycemic control with a mean HbA1c of 9.2 ± 0.837%. All had hypertension, macroalbuminuria, and DPN.
There is a well-recognized association between retinopathy and nephropathy, in which nephropathy without retinopathy is rare but retinopathy without nephropathy is common. We have identified a subset of patients with kidney disease of sufficient severity to warrant renal transplant but who are protected from retinopathy. It is possible that there is an extreme phenotype of DN patients with unaffected eyes who carry genes protecting against DR.
糖尿病患者的肾脏和眼部变化通常被认为是一致的。然而,有相当数量的糖尿病患者患有终末期肾病(ESRD),却没有任何典型的眼部变化。本研究强调了视网膜病变和肾病之间的不一致性,并描述了一系列长期患有糖尿病且接受肾移植的患者,这些患者几乎没有视网膜病变的证据。
所有接受肾移植的ESRD患者均接受了全面的眼底评估,包括散瞳间接检眼镜检查、裂隙灯生物显微镜检查和眼底摄影。测定了患者的年龄、性别、身体参数(体重指数和血压)、糖尿病病程、糖化血红蛋白(HbA1c)、白蛋白肌酐比值以及糖尿病周围神经病变(DPN)的存在情况。如有可用资料,对肾脏组织病理学进行了复查。
5例糖尿病肾病(DN)患者接受了肾移植,没有糖尿病视网膜病变(DR)的证据,或每个眼底最多有两个微动脉瘤。所有患者年龄在50至65岁之间(平均±标准差 - 58.6±4.67)。糖尿病平均病程为16±2.91年。所有患者血糖控制不佳,平均HbA1c为9.2±0.837%。所有患者均患有高血压、大量蛋白尿和DPN。
视网膜病变和肾病之间存在一种公认的关联,其中无视网膜病变的肾病很少见,但无肾病的视网膜病变很常见。我们已经确定了一部分肾病严重程度足以进行肾移植但免受视网膜病变影响的患者。有可能存在一种未受影响眼睛的DN患者极端表型,其携带预防DR的基因。